Successful treatment of cutaneous langerhans cell histiocytosis with thalidomide

Dermatology

Volumn 208, Issue 2, 2004, Pages 149-152

  Sander, C S ^a   Kaatz, M ^a   Elsner, P ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Cladribine; Langerhans cell histiocytosis; Thalidomide

Indexed keywords

CLADRIBINE; THALIDOMIDE;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; FATIGUE; GENERAL CONDITION IMPROVEMENT; HISTIOCYTOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LANGERHANS CELL HISTIOCYTOSIS; MALE; PRIORITY JOURNAL; REMISSION; SIDE EFFECT; SKIN BIOPSY; SKIN DISEASE; WOUND HEALING;

ADMINISTRATION, ORAL; ADULT; BIOPSY, NEEDLE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; MALE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SKIN DISEASES; THALIDOMIDE; TREATMENT OUTCOME;

EID: 1842475764     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076491     Document Type: Article

References (17)

1. Gadner H, Grois N, Arico M, Broadbent V, Ceci A, Jakobson A, Komp D, Michaelis J, Nicholson S, Potschger U, Pritchard J, Ladisch S: A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. J Pediatr 2001;138:728-734.
2. Gnassia A, Gnassia R, Bonvalet D, Puissant A, Goudal H: Histiocytose X avec 'granulome éosinophile vulvaire'. Effet spectaculaire de la thalidomide. Ann Dermatol Venereol 1987;114:1387-1389.
3. Thomas L, Ducros B, Secchi T, Balme B, Moulin G: Successful treatment of adult's Langerhans cell histiocytosis with thalidomide. Report of two cases and literature review. Arch Dermatol 1993;129:1261-1264.
4. Gerlach B, Stein A, Fischer R, Wozel G, Dittert DD, Richter G: Langerhans cell histiocytosis in the elderly (in German). Hautarzt 1998;49:23-30.
5. Lair G, Marie I, Cailleux N, Blot E, Bouillie MC, Courville P, Lauret P, Levesque H, Courtois H: Langerhans histiocytosis in adults: Cutaneous and mucous lesion regression after treatment with thalidomide (in French). Rev Med Interne 1998;19:196-198.
6. Kolde G, Schulze P, Sterry W: Mixed response to thalidomide therapy in adults: Two cases of multisystem Langerhans' cell histiocytosis. Acta Derm Venereol 2002;82:384-386.
7. Bensaid P, Machet L, Vaillant L, Machet MC, ScottoB, Lorette G: Langerhans-cell histiocytosis in the adult: Regressive parotid involvement following thalidomide therapy. Ann Dermatol Venereol 1992;119:281-283.
8. Claudon A, Dietemann JL, Hamman De Compte A, Hassler P: Interest in thalidomide in cutaneo-mucous and hypothalamo-hypophyseal involvement of Langerhans cell histiocytosis (in French). Rev Med Interne 2002;23:651-656.
9. Dallafior S, Pugin P, Cerny T, Betticher D, Saurat JH, Hauser C: Successful treatment of a case of cutaneous Langerhans cell granulomatosis with 2-chlorodeoxyadenosine and thalidomide (in German). Hautarzt 1995;46:553-560.
10. Meunier L, Marck Y, Ribeyre C, Meynadier J: Adult cutaneous Langerhans cell histiocytosis: Remission with thalidomide treatment. Br J Dermatol 1995;132:168.
11. Misery L, Larbre B, Lyonnet S, Faure M, Thivolet J: Remission of Langerhans cell histiocytosis with thalidomide treatment. Clin Exp Dermatol 1993;18:487.
12. Bastuji-Garin S, Ochonisky S, Bouche P, Gheraurdi RK, Duguet C, Djerradine Z, Poli F, Revuz J: Incidence and risk factors for thalidomide neuropathy: A prospective study of 135 dermatologic patients. J Invest Dermatol 2002;119:1020-1026.
13. Allen BR: Thalidomide. Br J Dermatol 2001;144:227-228.
14. Meierhofer C, Dunzendorfer S, Wiedermann CJ: Theoretical basis for the activity of thalidomide. BioDrugs 2001;15:681-703.
15. Egeler RM, Favara BE, van Meurs M, Laman JD, Claassen E: Differential in situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: Abundant expression of cytokines relevant to disease and treatment. Blood 1999;94:4195-4201.
16. Tazi A, Moreau J, Bergeron A, Dominique S, Hance AJ, Soler P: Evidence that Langerhans cells in adult pulmonary Langerhans cell histiocytosis are mature dendritic cells: Importance of the cytokine microenvironment. J Immunol 1999;163:3511-3515.
17. Henter JI, Karlen J, Calming U, Bernstrand C, Andersson U, Fadeel B: Successful treatment of Langerhans'-cell histiocytosis with etanercept. N Engl J Med 2001;345:1577-1578.